ABBV - AbbVie Inc.
229.89
1.100 0.478%
Share volume: 1,744,910
Last Updated: 12-24-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$228.79
1.10
0.00%
Summary score
62%
Profitability
65%
Dept financing
50%
Liquidity
40%
Performance
67%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
26.17%
Return on assets
1.81%
Return on sales
24.65%
Return on invested capital
4.83%
Total debt ratio
93.28%
Debt ratio change over timeo
21.11%
Current Ratio
0.83%
Quick Ratio
0.72%
Cash Position Ratio
0.26%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0.78%
Return on sales
15.48%
Return on invested capital
0%
Total debt ratio
99.65%
Debt ratio change over timeo
0%
Current Ratio
0.72%
Quick Ratio
0.6%
Cash Position Ratio
0.15%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
1.03%
Return on sales
12.07%
Return on invested capital
0%
Total debt ratio
101.97%
Debt ratio change over time
0%
Current Ratio
0.72%
Quick Ratio
0.6%
Cash Position Ratio
0.14%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
657.11%
Return on assets
-6.42%
Return on sales
792.83%
Return on invested capital
39.86%
Total debt ratio
2111.21%
Debt ratio change over time
21.11%
Current Ratio
18.91%
Quick Ratio
16.52%
Cash Position Ratio
4.98%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABBV | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 26.17% | 13.23% | 9.84% | 0% |
| Return on assets | 1.81% | 4.59% | 3.2% | 0% |
| Return on sales | 24.65% | 30.04% | 25.15% | 0% |
| Return on invested capital | 4.83% | 8.51% | 10.28% | 0% |
| Profitability | 67% | 83% | 73% | 0% |
| Total debt ratio | 93.28% | 80.7% | 59.39% | 0% |
| Debt ratio change over time | 21.11% | -16.59% | -73.52% | 0% |
| Dept financing | 50% | 22% | 16% | 0% |
| Current Ratio | 0.72% | 1.34% | 1.11% | 0% |
| Quick Ratio | 0.6% | 1.05% | 0.86% | 0% |
| Cash Position Ratio | 0.15% | 0.14% | 0.46% | 0% |
| Liquididy | 49% | 57% | 75% | 0% |
| Short-term ratios | ABBV | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 0.78% | 5.82% | 4.08% | 0% |
| Return on sales | 15.48% | 38.27% | 25.36% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 63% | 50% | 34% | 0% |
| Total debt ratio | 99.65% | 81.38% | 59.57% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 20% | 15% | 0% |
| Current Ratio | 0.72% | 1.34% | 1.11% | 0% |
| Quick Ratio | 0.6% | 1.05% | 0.86% | 0% |
| Cash Position Ratio | 0.15% | 0.14% | 0.46% | 0% |
| Liquididy | 36% | 58% | 66% | 0% |